Why is Akums Drugs falling/rising?

As of 25-Jul, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 530.25, reflecting a decrease of 7.6 points or 1.41%. The stock has underperformed its sector by 1.58% today and has been on a consecutive downward trend for the last two days, with a total drop of 2.11% in that period. Additionally, the stock's performance over the past week shows a decline of 4.22%, and over the past month, it has fallen by 7.59%. While the company has reported positive financial results, including a significant growth in PAT and net sales, the long-term growth prospects appear weak, with net sales growing at an annual rate of only 6.10% over the last five years, which may be contributing to investor concerns.
In the broader market context, the Sensex has only decreased by 0.36% over the past week, indicating that Akums Drugs is underperforming relative to the benchmark. The stock's liquidity is adequate for trading, but there has been a notable drop in investor participation, with delivery volume falling by 72.27% compared to the five-day average. This decline in trading activity, coupled with the stock's poor long-term growth outlook, suggests that investors may be cautious, leading to the recent price drop despite the company's attractive valuation metrics.